Advertisement
Screener

Journey Medical Corp (DERM) Selling, General and Administrative Expense

2.8 / 5 stars · 68/120 Roast Me

Journey Medical Corp Selling, General and Administrative Expense

Journey Medical Corp (DERM) reported Selling, General and Administrative Expense of $10.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-12

  • Journey Medical Corp selling, general and administrative expense for the quarter ending 2026-06-30 was $10.89M, a 8.37% decline year-over-year.
  • Journey Medical Corp selling, general and administrative expense for the quarter ending 2026-03-31 was $10.11M, a 4.35% decline year-over-year.
  • Journey Medical Corp selling, general and administrative expense for the quarter ending 2025-12-31 was $9.86M, a 1.96% decline year-over-year.
  • Journey Medical Corp selling, general and administrative expense for the quarter ending 2025-09-30 was $12.05M, a 5.77% increase year-over-year.
  • Journey Medical Corp selling, general and administrative expense for fiscal 2025 was $44.37M, a 10.36% increase from fiscal 2024.
  • Journey Medical Corp selling, general and administrative expense for fiscal 2024 was $40.20M, a 8.44% decline from fiscal 2023.
  • Journey Medical Corp selling, general and administrative expense for fiscal 2023 was $43.91M, a 26.16% decline from fiscal 2022.
  • Journey Medical Corp selling, general and administrative expense for fiscal 2022 was $59.47M, a 49.29% increase from fiscal 2021.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 12 month
2026-06-30$10.89M
10-Q · filed 2026-08-12
$21.00M
10-Q · filed 2026-08-12
$30.86M
derived: sum of 3 quarters · filed 2026-08-12
$42.91M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$10.11M
10-Q · filed 2026-05-13
$19.97M
derived: sum of 2 quarters · filed 2026-05-13
$32.03M
derived: sum of 3 quarters · filed 2026-05-13
$43.91M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$9.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$21.92M
derived: sum of 2 quarters · filed 2026-03-26
$33.80M
derived: sum of 3 quarters · filed 2026-08-12
$44.37M
10-K · filed 2026-03-26
2025-09-30$12.05M
10-Q · filed 2025-11-12
$23.94M
derived: sum of 2 quarters · filed 2026-08-12
$34.51M
10-Q · filed 2025-11-12
$44.56M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$11.88M
10-Q · filed 2026-08-12
$22.45M
10-Q · filed 2026-08-12
$32.51M
derived: sum of 3 quarters · filed 2026-08-12
$43.91M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$10.57M
10-Q · filed 2026-05-13
$20.63M
derived: sum of 2 quarters · filed 2026-05-13
$32.02M
derived: sum of 3 quarters · filed 2026-05-13
$42.35M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$10.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$21.46M
derived: sum of 2 quarters · filed 2026-03-26
$31.78M
derived: sum of 3 quarters · filed 2026-03-26
$40.20M
10-K · filed 2026-03-26
2024-09-30$11.40M
10-Q · filed 2025-11-12
$21.72M
derived: sum of 2 quarters · filed 2025-11-12
$30.14M
10-Q · filed 2025-11-12
$39.98M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$10.33M
10-Q · filed 2025-08-12
$18.75M
10-Q · filed 2025-08-12
$28.59M
derived: sum of 3 quarters · filed 2025-08-12
$37.23M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$8.42M
10-Q · filed 2025-05-15
$18.26M
derived: sum of 2 quarters · filed 2025-05-15
$26.90M
derived: sum of 3 quarters · filed 2025-05-15
$39.04M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$9.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$18.48M
derived: sum of 2 quarters · filed 2025-03-27
$30.62M
derived: sum of 3 quarters · filed 2025-03-27
$43.91M
10-K · filed 2025-03-27
2023-09-30$8.64M
10-Q · filed 2024-11-12
$20.78M
derived: sum of 2 quarters · filed 2024-11-12
$34.07M
10-Q · filed 2024-11-12
$48.06M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$12.14M
10-Q · filed 2024-08-13
$25.43M
10-Q · filed 2024-08-13
$39.42M
derived: sum of 3 quarters · filed 2024-08-13
$54.99M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$13.29M
10-Q · filed 2024-05-14
$27.28M
derived: sum of 2 quarters · filed 2024-05-14
$42.85M
derived: sum of 3 quarters · filed 2024-05-14
$58.05M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$13.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$29.56M
derived: sum of 2 quarters · filed 2024-03-29
$44.75M
derived: sum of 3 quarters · filed 2024-03-29
$59.47M
10-K · filed 2024-03-29
2022-09-30$15.57M
10-Q · filed 2023-11-13
$30.77M
derived: sum of 2 quarters · filed 2023-11-13
$45.48M
10-Q · filed 2023-11-13
$60.54M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$15.19M
10-Q · filed 2023-08-10
$29.91M
10-Q · filed 2023-08-10
$44.96M
derived: sum of 3 quarters · filed 2023-08-10
$55.72M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$14.71M
10-Q · filed 2023-05-22
$29.77M
derived: sum of 2 quarters · filed 2023-05-22
$40.53M
derived: sum of 3 quarters · filed 2023-05-22
$48.32M
derived: sum of 4 quarters · filed 2023-05-22
2021-12-31$15.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$25.81M
derived: sum of 2 quarters · filed 2023-03-31
$33.61M
derived: sum of 3 quarters · filed 2023-03-31
$39.83M
10-K · filed 2023-03-31
2021-09-30$10.76M
10-Q · filed 2022-11-10
$18.55M
derived: sum of 2 quarters · filed 2022-11-10
$24.78M
10-Q · filed 2022-11-10
$30.59M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$7.79M
10-Q · filed 2022-08-09
$14.02M
10-Q · filed 2022-08-09
$19.84M
derived: sum of 3 quarters · filed 2022-08-09
$25.67M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$6.23M
10-Q · filed 2022-05-10
$12.04M
derived: sum of 2 quarters · filed 2022-05-10
$17.87M
derived: sum of 3 quarters · filed 2022-05-10
2020-12-31$5.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$11.64M
derived: sum of 2 quarters · filed 2022-03-28
$22.09M
10-K · filed 2022-03-28
2020-09-30$5.83M
10-Q · filed 2021-12-16
$16.27M
10-Q · filed 2021-12-16